EVOLUS, INC. Shares Outstanding (Cover Page)
EVOLUS, INC. (EOLS) had Shares Outstanding (Cover Page) of 66.05 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 66.05M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 65.85M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 65.06M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 64.82M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 66.05M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 65.85M shares 10-Q · filed 2026-05-04 |
| 2026-02-27 | 65.06M shares 10-K · filed 2026-03-03 |
| 2025-10-31 | 64.82M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 64.69M shares 10-Q · filed 2025-08-05 |
| 2025-05-02 | 64.48M shares 10-Q · filed 2025-05-07 |
| 2025-02-28 | 63.59M shares 10-K · filed 2025-03-04 |
| 2024-11-01 | 63.32M shares 10-Q · filed 2024-11-06 |
| 2024-07-26 | 63.09M shares 10-Q · filed 2024-07-31 |
| 2024-05-03 | 62.61M shares 10-Q · filed 2024-05-07 |
| 2024-03-01 | 57.94M shares 10-K · filed 2024-03-07 |
| 2023-11-03 | 57.15M shares 10-Q · filed 2023-11-07 |
| 2023-07-28 | 56.97M shares 10-Q · filed 2023-08-02 |
| 2023-05-05 | 56.92M shares 10-Q · filed 2023-05-09 |
| 2023-03-03 | 56.41M shares 10-K · filed 2023-03-08 |
| 2022-11-04 | 56.25M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 56.09M shares 10-Q · filed 2022-08-02 |
| 2022-05-06 | 56.05M shares 10-Q · filed 2022-05-10 |
| 2022-02-28 | 55.69M shares 10-K · filed 2022-03-03 |
| 2021-10-29 | 55.58M shares 10-Q · filed 2021-11-02 |
| 2021-08-02 | 54.58M shares 10-Q · filed 2021-08-04 |
| 2021-05-07 | 54.12M shares 10-Q · filed 2021-05-12 |
| 2021-03-25 | 43.73M shares 10-K · filed 2021-03-25 |
| 2020-10-26 | 33.75M shares 10-Q · filed 2020-10-29 |
| 2020-08-05 | 33.75M shares 10-Q · filed 2020-08-10 |
| 2020-05-08 | 33.73M shares 10-Q · filed 2020-05-11 |
| 2020-02-21 | 33.73M shares 10-K · filed 2020-02-25 |
| 2019-11-01 | 27.43M shares 10-Q · filed 2019-11-04 |
| 2019-08-06 | 27.42M shares 10-Q · filed 2019-08-12 |
| 2019-04-26 | 27.33M shares 10-Q · filed 2019-05-01 |
| 2019-03-20 | 27.27M shares 10-K · filed 2019-03-20 |
| 2018-11-01 | 27.27M shares 10-Q · filed 2018-11-05 |
| 2018-08-01 | 26.67M shares 10-Q · filed 2018-08-02 |
| 2018-05-10 | 23.64M shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |